Skip to main content
Steven Sloan, MD, Pathology, Boston, MA

Steven R Sloan MD

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology


Blood Bank Medical Director at Boston Children's Hospital

Join to View Full Profile
  • 300 Longwood AveBader 4Boston, MA 02115

  • Phone+1 617-355-6268

Dr. Sloan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 1994 - 1996
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1990 - 1994
  • New York University School of Medicine
    New York University School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - Present
  • MA State Medical License
    MA State Medical License 2000 - 2022
  • PA State Medical License
    PA State Medical License 1993 - 1996
  • Clinical Pathology
    American Board of Pathology Clinical Pathology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Assessment of the Plasmic Score Utility for Classification of Pediatric Thrombotic Microangiopathies
    Steven Richard Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • By Steven L Spitalnik Md Clinical Pathology Board Review 1e 1 Harpsc Paperback
    By Steven L Spitalnik Md Clinical Pathology Board Review 1e 1 Harpsc PaperbackJune 27th, 2020
  • Targeted Genomic CRISPR-Cas9 Screen Identifies MAP4K4 as Essential for Glioblastoma Invasion
    Targeted Genomic CRISPR-Cas9 Screen Identifies MAP4K4 as Essential for Glioblastoma InvasionSeptember 30th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: